研究者検索結果一覧 小澤 敬也 小澤 敬也オザワ ケイヤ (Keiya Ozawa) ダウンロードする帳票の形式を下記より選択して下さい 「教育研究等環境」形式 「文科省帳票様式第4号 ①履歴書」形式 「文科省帳票様式第4号 ②教育研究業績書」形式 基本情報 所属自治医科大学(JMU) 教授学位医学博士(東京大学)J-GLOBAL ID200901030330125009researchmap会員ID0000018135 研究キーワード 6 AAVベクター 造血幹細胞 遺伝子治療 AAV vector Hematopietic stem cell gene therapy 研究分野 1 ライフサイエンス / 血液、腫瘍内科学 / 経歴 72 2002年 4月 自治医科大学分子病態治療研究センター 2001年3月 (輸血部より改称)(部長兼任は2001年3月まで) 2001年 4月 東北大学大学院医学系研究科大学院非常勤講師 2000年10月 月 自治医科大学内科学講座血液学部門主任教授 2000年 4月 自治医科大学総合診療部医員(兼任) もっとみる 学歴 2 - 1977年 東京大学 医学部 医学科 - 1977年 University of Tokyo Faculty of Medicine 委員歴 7 2000年 - 2001年 国際実験血液学会 ISEH Standing Scientific Program Committee Member 1999年 日本癌学会 評議員 1996年 がん分子標的治療研究会 世話人 1994年 日本遺伝子治療学会 幹事、評議員、プログラム委員 1994年 日本ウイルス学会 将来計画委員会(将来構想検討委員会)委員 もっとみる 受賞 2 1999年 平成11年度日本医師会医学研究助成賞 1999. Grant-in-Aid of The Japan Medical Association MISC 501 Chronic bone marrow failure due to persistent B19 parvovirus infection. N.Engl.J.Med.317:287-294,1987. Charged-to-alanine scanning mutagenesis of N-terminal half of adeno-associated virus type 2 Rep78 protein. J.Virol.(in press) Charged-to alanine scanning mutagenesis of the N-terminal half of adeno-associated virus type 2 Rep78 protein. J. Virol.73: 2682-2693, 1999. Characterization of transformed hematopoietic cells afier activated ras gene transfection. In, Myelodysplastic Syndromes: Advances in Research and Treatment. Elsevier Science B.V.p.237-243,1995. Characterization of the kinase activity essential for tyrosine phosphorylation of pl30cas in fibroblasts. Oncogene14:1419-1426,1997. Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroidbone marrow cell cultures. J.Virol.61:2627-2630, 1987. Characteristics of granulocyte-macrophage colony formation in patients with chronic myelomonocytic Leukemia Stem Cells1:345-353,1981 Changes in hematopoiesis-supporting ability of C3HIOTl/2 mouse embryo fibroblasts during differentiation. Blood 81:1184-l192,1993. Case report: Alternation therapy with antileukemic agents and recombinant human granulocyte colony-stimulating factor for RAEB in transformation. Am.J.Med.Sci.303:316-318,1992. Case report. Hemophagocytosis as a para-neoplastic syndrome in NK cell leukemia. Int.J.Hematol.64:135-142,1996. Biological activity of C-terminus modified version of human granulocyte colony-stimulating factor. Biochem.Biophys.Res.Commun.(in press) Binding of membrane-anchored macrophage colony-stimulating factor (M-CSF) to its receptor mediates specific adhesion between stromal cells and M-CSF receptor-bearing hematopoietic cells. Blood 82:2634-2640,1993. Behavioral recovery in 6-hydroxydopamine-lesioned rats by cotransduction of striatum with tyrosine hydroxylase and aromatic L-amino acid decarboxylase genes using two separate adeno-associated virus vectors. Hum. Gene Ther.9:2527-2535,1998. Basic studies toward hematopoietic stem cell gene therapy. In, Cell Therapy (ed. by Ikeda, Y., Hata, J., Koyasu, S., Kawakami, Y., Hattori, Y.) Springer-Verlag, Tokyo, p.159-169, 2000. B19 parvovirus replicates in erythroid leukemia cells in vitro. J.Infect.Dis.160:548-549,1989. Autologous peripheral blood stem cell transplantation for adults with B-lineage acute lymphoblastic leukemia: a pilot study. Leukemia Lymphoma 38: 103-111, 2000. Autologous bone marrow transplantation for patients with advanced chronic myelogenous leukemia. Int.J.Hematol.66:493-503,1997. Apoptosis-mediated regulation of recombinant human granulocyte eolony-stimulating factor production by genetically engineered fibroblasts. Gene Ther.5:923-929,1998. Adult T-cell lenkemia developing during immunosuppressive treatment in a renal transplant recipient. Am.J.Hematol.41:292-294,1992. Adhesion of NFS-60 myeloid leukemia cells to MC3T3-G2/PA6 stromal cells induces granulocyte colony-stimulating factor production. Blood 84:415-420,l994. Adeno-associated virus vector-mediated bcl-2 gene transfer into post-ischemic gerbil brain in vivo: prospects for gene therapy of ischemia-induced neuronal death. Gene Ther. 7: 1244-1249, 2000. Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome. J.Virol.71:7951-7959,1997. Adeno-associated virus (AAV) vectors and gene therapy of Parkinson's disease. In, Progress in Gene Therapy-Basic and Clinical Frontiers. (ed. by Bertolotti, R., Parvez, S. H., and Nagatsu, T.) VSP BV, Natherlands, pp.289-306, 2000. Acquisition of IL-3-independence in FDC-P2 cells after transfection with the activated c-H-rasgene using a bovine papillomavirus-based plasmid vector. Blood 80:3198-3204,1992. Acceleration of neutrophilic granulocyte recovery in bone recombinant human granulocyte colony marrow transplanted patients by administration. Lancetii:38-39, 1988. A synergistic increase in transplantable peripheral blood stem cells in mice by co-administration of recombinant human interleukin 6 and recombinant human granulocyte colony-stimulating factor. Transplantation59:1596-1600,1995. A selective amplifier gene for tamoxifen-inducible expansion of hematopoietic cells. J. Gene Med. 1:236-244, 1999. A possible correlation between the type of bcr-abl hybrid messenger RNA and platelet count in Philadelphia-positive chronic myelogenous leukemia. Blood 78:3125-3127,1991 A novel strategy for the tumor angiogenesis-targeted gene therapy: Generation of angiostatin endogenous plasminogen by protease gene transfer. Cancer Gene Ther. 7: 589-596, 2000. A novel selective amplifier gene for hematopoietic stem cell gene therapy. Cancer Res.Ther.Contr.7:27-31,1998. A novel gene (drad-J) expressed in hematopoiesis-supporting stromal cell lines, ST2, PA6 and A54 preadipocytes:Use of mRNA differential display Stem Cells15:334-339,1997. A novel dicistronic AAV (adeno-associated virus) vector using a short IRES (internal ribosome entry site) segment derived from hepatitis C virus genome. Gene 200: 157-162, 1997. A new method for permanent preparations of hemopoietic cells in methylcellulose medium. Hematol.10:145-150,1982. A new apoptotic pathway for the complement factor B-derived fragment Bbeta. J. Cell. Physiol. 185: 280-292, 2000. A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction. Blood 96: 941-949, 2000. A case of myelodysplastic syndrome (refractory anemia) transforming into acute leukemia with monosomy 7 afier administration of granulocyte colony-stimulating factor. In, Myelodysplastic Syndromes: Advances in Research and Treatment. Elsevier Science B.V, p.357-359, 1995. A case of bilateral heel ulcers associated with hydroxyurea therapy for chronic myelogenous leukemia. Jpn. J. Clin. Oncol. 30: 159-162, 2000. A Stu I polymorphism in the human granulocyte colony-stimulating factor gene. Nucl.Acid Res.17:7544,1989. A functional role of mitogen-activated protein kinases, Erk1 and Erk2, in the differentiation of a human leukemia cell line, UT-7/GM: A possible key factor for cell fate determination toward erythroid and megakaryocytic lineages. Int. J. Hematol. 73 : 78-83, 2001. g-Rays enhance rAAV-mediated transgene expression and cytocidal effect of AAV-HSVtk / ganciclovir on cancer cells. Cancer Gene Ther. 8 : 99-106, 2001 Forkhead family transcription factor FKHRL1 is expressed in human megakaryocytes and regulates cell cycling as a downstream molecule of TPO signaling. J. Biol. Chem. 276 : 15082-15089, 2001. Morphological and physiological restorations of hereditary form of dilated cardiomyopathy by somatic gene therapy. Biochem. Biophys. Res. Commun. 284 : 431-435, 2001. Antitumor effect of beta2-microglobulin in leukemic cell-bearing mice via apoptosis-inducing activity : activation of caspase-3 and nuclear factor-kappaB. Cancer Res. 61 : 4414-4417, 2001. CD13 is the resistance mechanism for endothelial interleukin-8 inducing apoptosis. In, Cell-Surface Aminopeptidases : Basic and Clinical Aspects. (ed. by Mizutani, S.and Turner, A.J.) Elsevier Science B.V., p. 177-184, 2001. Adeno-associated virus-mediated transfer of endothelial nitric oxide synthase gene reduces vasoconstrictive response. Exp. Clin. Cardiol. 6 : 50-55, 2001. A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus. Hum. Gene Ther. 12 : 1047-1061, 2001. Targeted integration of foreign dna into a defined locus on chromosome 19 in K562 cells using MV-derived components. Int. J. Hematol. 73 : 469-475, 2001. Adeno-associated virus-mediated transfer of endothelial nitric oxide synthase gene inhibits protein synthesis of rat ventricular cardiomyocytes. Cardiovas. Drug Ther. 15 : 19-24, 2001. Colon cancer with meningeal carcinomatosis and myelodysplastic syndrome in a patient who underwent intensive chemotherapy for acute myelogenous leukemia : a case report. Jpn. J. Clin. Oncol. 31: 221-225, 2001. beta2-Microglobulin identified as an apoptosis-inducing factor and its characterization. Blood 94: 2744-2753, 1999. «56789» 所属学協会 40 日本再生医療学会 米国微生物学会 米国血液学会 米国科学振興協会 米国医学研究連合 もっとみる 共同研究・競争的資金等の研究課題 6 遺伝子治療 ミレニアム・プロジェクト 遺伝子治療 厚生労働科学研究費補助金 遺伝子治療 科学研究費補助金 Gene therapy Millennium Project Gene therapy Health and Labour Sciences Research Grants もっとみる
小澤 敬也オザワ ケイヤ (Keiya Ozawa) ダウンロードする帳票の形式を下記より選択して下さい 「教育研究等環境」形式 「文科省帳票様式第4号 ①履歴書」形式 「文科省帳票様式第4号 ②教育研究業績書」形式 基本情報 所属自治医科大学(JMU) 教授学位医学博士(東京大学)J-GLOBAL ID200901030330125009researchmap会員ID0000018135 研究キーワード 6 AAVベクター 造血幹細胞 遺伝子治療 AAV vector Hematopietic stem cell gene therapy 研究分野 1 ライフサイエンス / 血液、腫瘍内科学 / 経歴 72 2002年 4月 自治医科大学分子病態治療研究センター 2001年3月 (輸血部より改称)(部長兼任は2001年3月まで) 2001年 4月 東北大学大学院医学系研究科大学院非常勤講師 2000年10月 月 自治医科大学内科学講座血液学部門主任教授 2000年 4月 自治医科大学総合診療部医員(兼任) もっとみる 学歴 2 - 1977年 東京大学 医学部 医学科 - 1977年 University of Tokyo Faculty of Medicine 委員歴 7 2000年 - 2001年 国際実験血液学会 ISEH Standing Scientific Program Committee Member 1999年 日本癌学会 評議員 1996年 がん分子標的治療研究会 世話人 1994年 日本遺伝子治療学会 幹事、評議員、プログラム委員 1994年 日本ウイルス学会 将来計画委員会(将来構想検討委員会)委員 もっとみる 受賞 2 1999年 平成11年度日本医師会医学研究助成賞 1999. Grant-in-Aid of The Japan Medical Association MISC 501 Chronic bone marrow failure due to persistent B19 parvovirus infection. N.Engl.J.Med.317:287-294,1987. Charged-to-alanine scanning mutagenesis of N-terminal half of adeno-associated virus type 2 Rep78 protein. J.Virol.(in press) Charged-to alanine scanning mutagenesis of the N-terminal half of adeno-associated virus type 2 Rep78 protein. J. Virol.73: 2682-2693, 1999. Characterization of transformed hematopoietic cells afier activated ras gene transfection. In, Myelodysplastic Syndromes: Advances in Research and Treatment. Elsevier Science B.V.p.237-243,1995. Characterization of the kinase activity essential for tyrosine phosphorylation of pl30cas in fibroblasts. Oncogene14:1419-1426,1997. Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroidbone marrow cell cultures. J.Virol.61:2627-2630, 1987. Characteristics of granulocyte-macrophage colony formation in patients with chronic myelomonocytic Leukemia Stem Cells1:345-353,1981 Changes in hematopoiesis-supporting ability of C3HIOTl/2 mouse embryo fibroblasts during differentiation. Blood 81:1184-l192,1993. Case report: Alternation therapy with antileukemic agents and recombinant human granulocyte colony-stimulating factor for RAEB in transformation. Am.J.Med.Sci.303:316-318,1992. Case report. Hemophagocytosis as a para-neoplastic syndrome in NK cell leukemia. Int.J.Hematol.64:135-142,1996. Biological activity of C-terminus modified version of human granulocyte colony-stimulating factor. Biochem.Biophys.Res.Commun.(in press) Binding of membrane-anchored macrophage colony-stimulating factor (M-CSF) to its receptor mediates specific adhesion between stromal cells and M-CSF receptor-bearing hematopoietic cells. Blood 82:2634-2640,1993. Behavioral recovery in 6-hydroxydopamine-lesioned rats by cotransduction of striatum with tyrosine hydroxylase and aromatic L-amino acid decarboxylase genes using two separate adeno-associated virus vectors. Hum. Gene Ther.9:2527-2535,1998. Basic studies toward hematopoietic stem cell gene therapy. In, Cell Therapy (ed. by Ikeda, Y., Hata, J., Koyasu, S., Kawakami, Y., Hattori, Y.) Springer-Verlag, Tokyo, p.159-169, 2000. B19 parvovirus replicates in erythroid leukemia cells in vitro. J.Infect.Dis.160:548-549,1989. Autologous peripheral blood stem cell transplantation for adults with B-lineage acute lymphoblastic leukemia: a pilot study. Leukemia Lymphoma 38: 103-111, 2000. Autologous bone marrow transplantation for patients with advanced chronic myelogenous leukemia. Int.J.Hematol.66:493-503,1997. Apoptosis-mediated regulation of recombinant human granulocyte eolony-stimulating factor production by genetically engineered fibroblasts. Gene Ther.5:923-929,1998. Adult T-cell lenkemia developing during immunosuppressive treatment in a renal transplant recipient. Am.J.Hematol.41:292-294,1992. Adhesion of NFS-60 myeloid leukemia cells to MC3T3-G2/PA6 stromal cells induces granulocyte colony-stimulating factor production. Blood 84:415-420,l994. Adeno-associated virus vector-mediated bcl-2 gene transfer into post-ischemic gerbil brain in vivo: prospects for gene therapy of ischemia-induced neuronal death. Gene Ther. 7: 1244-1249, 2000. Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome. J.Virol.71:7951-7959,1997. Adeno-associated virus (AAV) vectors and gene therapy of Parkinson's disease. In, Progress in Gene Therapy-Basic and Clinical Frontiers. (ed. by Bertolotti, R., Parvez, S. H., and Nagatsu, T.) VSP BV, Natherlands, pp.289-306, 2000. Acquisition of IL-3-independence in FDC-P2 cells after transfection with the activated c-H-rasgene using a bovine papillomavirus-based plasmid vector. Blood 80:3198-3204,1992. Acceleration of neutrophilic granulocyte recovery in bone recombinant human granulocyte colony marrow transplanted patients by administration. Lancetii:38-39, 1988. A synergistic increase in transplantable peripheral blood stem cells in mice by co-administration of recombinant human interleukin 6 and recombinant human granulocyte colony-stimulating factor. Transplantation59:1596-1600,1995. A selective amplifier gene for tamoxifen-inducible expansion of hematopoietic cells. J. Gene Med. 1:236-244, 1999. A possible correlation between the type of bcr-abl hybrid messenger RNA and platelet count in Philadelphia-positive chronic myelogenous leukemia. Blood 78:3125-3127,1991 A novel strategy for the tumor angiogenesis-targeted gene therapy: Generation of angiostatin endogenous plasminogen by protease gene transfer. Cancer Gene Ther. 7: 589-596, 2000. A novel selective amplifier gene for hematopoietic stem cell gene therapy. Cancer Res.Ther.Contr.7:27-31,1998. A novel gene (drad-J) expressed in hematopoiesis-supporting stromal cell lines, ST2, PA6 and A54 preadipocytes:Use of mRNA differential display Stem Cells15:334-339,1997. A novel dicistronic AAV (adeno-associated virus) vector using a short IRES (internal ribosome entry site) segment derived from hepatitis C virus genome. Gene 200: 157-162, 1997. A new method for permanent preparations of hemopoietic cells in methylcellulose medium. Hematol.10:145-150,1982. A new apoptotic pathway for the complement factor B-derived fragment Bbeta. J. Cell. Physiol. 185: 280-292, 2000. A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction. Blood 96: 941-949, 2000. A case of myelodysplastic syndrome (refractory anemia) transforming into acute leukemia with monosomy 7 afier administration of granulocyte colony-stimulating factor. In, Myelodysplastic Syndromes: Advances in Research and Treatment. Elsevier Science B.V, p.357-359, 1995. A case of bilateral heel ulcers associated with hydroxyurea therapy for chronic myelogenous leukemia. Jpn. J. Clin. Oncol. 30: 159-162, 2000. A Stu I polymorphism in the human granulocyte colony-stimulating factor gene. Nucl.Acid Res.17:7544,1989. A functional role of mitogen-activated protein kinases, Erk1 and Erk2, in the differentiation of a human leukemia cell line, UT-7/GM: A possible key factor for cell fate determination toward erythroid and megakaryocytic lineages. Int. J. Hematol. 73 : 78-83, 2001. g-Rays enhance rAAV-mediated transgene expression and cytocidal effect of AAV-HSVtk / ganciclovir on cancer cells. Cancer Gene Ther. 8 : 99-106, 2001 Forkhead family transcription factor FKHRL1 is expressed in human megakaryocytes and regulates cell cycling as a downstream molecule of TPO signaling. J. Biol. Chem. 276 : 15082-15089, 2001. Morphological and physiological restorations of hereditary form of dilated cardiomyopathy by somatic gene therapy. Biochem. Biophys. Res. Commun. 284 : 431-435, 2001. Antitumor effect of beta2-microglobulin in leukemic cell-bearing mice via apoptosis-inducing activity : activation of caspase-3 and nuclear factor-kappaB. Cancer Res. 61 : 4414-4417, 2001. CD13 is the resistance mechanism for endothelial interleukin-8 inducing apoptosis. In, Cell-Surface Aminopeptidases : Basic and Clinical Aspects. (ed. by Mizutani, S.and Turner, A.J.) Elsevier Science B.V., p. 177-184, 2001. Adeno-associated virus-mediated transfer of endothelial nitric oxide synthase gene reduces vasoconstrictive response. Exp. Clin. Cardiol. 6 : 50-55, 2001. A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus. Hum. Gene Ther. 12 : 1047-1061, 2001. Targeted integration of foreign dna into a defined locus on chromosome 19 in K562 cells using MV-derived components. Int. J. Hematol. 73 : 469-475, 2001. Adeno-associated virus-mediated transfer of endothelial nitric oxide synthase gene inhibits protein synthesis of rat ventricular cardiomyocytes. Cardiovas. Drug Ther. 15 : 19-24, 2001. Colon cancer with meningeal carcinomatosis and myelodysplastic syndrome in a patient who underwent intensive chemotherapy for acute myelogenous leukemia : a case report. Jpn. J. Clin. Oncol. 31: 221-225, 2001. beta2-Microglobulin identified as an apoptosis-inducing factor and its characterization. Blood 94: 2744-2753, 1999. «56789» 所属学協会 40 日本再生医療学会 米国微生物学会 米国血液学会 米国科学振興協会 米国医学研究連合 もっとみる 共同研究・競争的資金等の研究課題 6 遺伝子治療 ミレニアム・プロジェクト 遺伝子治療 厚生労働科学研究費補助金 遺伝子治療 科学研究費補助金 Gene therapy Millennium Project Gene therapy Health and Labour Sciences Research Grants もっとみる
The maximum number of documents to be output has been reached. 研究者氏名 部署 研究キーワード 研究分野大分類 -- 指定なし -- ライフサイエンス 情報通信 環境・農学 ナノテク・材料 エネルギー ものづくり技術(機械・電気電子・化学工学) 社会基盤(土木・建築・防災) フロンティア(航空・船舶) 人文・社会 自然科学一般 その他 小分類 -- 指定なし -- 検索 条件クリア